These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37086409)

  • 1. GlycoMME, a Markov modeling platform for studying N-glycosylation biosynthesis from glycomics data.
    Liang C; Chiang AWT; Lewis NE
    STAR Protoc; 2023 Apr; 4(2):102244. PubMed ID: 37086409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycomics-informed glycoproteomic analysis of site-specific glycosylation for SARS-CoV-2 spike protein.
    Rosenbalm KE; Tiemeyer M; Wells L; Aoki K; Zhao P
    STAR Protoc; 2020 Dec; 1(3):100214. PubMed ID: 33377107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Markov model of glycosylation elucidates isozyme specificity and glycosyltransferase interactions for glycoengineering.
    Liang C; Chiang AWT; Hansen AH; Arnsdorf J; Schoffelen S; Sorrentino JT; Kellman BP; Bao B; Voldborg BG; Lewis NE
    Curr Res Biotechnol; 2020 Nov; 2():22-36. PubMed ID: 32285041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-Based Glycan Arrays-A Practical Guide to Dissect the Human Glycome.
    Büll C; Joshi HJ; Clausen H; Narimatsu Y
    STAR Protoc; 2020 Jun; 1(1):100017. PubMed ID: 33111073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparing glycomics data for robust statistical analysis with GlyCompareCT.
    Zhang Y; Krishnan S; Bao B; Chiang AWT; Sorrentino JT; Schinn SM; Kellman BP; Lewis NE
    STAR Protoc; 2023 Mar; 4(2):102162. PubMed ID: 36920914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Big-Data Glycomics: Tools to Connect Glycan Biosynthesis to Extracellular Communication.
    Kellman BP; Lewis NE
    Trends Biochem Sci; 2021 Apr; 46(4):284-300. PubMed ID: 33349503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Integrated Mass Spectrometry-Based Glycomics-Driven Glycoproteomics Analytical Platform to Functionally Characterize Glycosylation Inhibitors.
    Alvarez MRS; Zhou Q; Grijaldo SJB; Lebrilla CB; Nacario RC; Heralde FM; Rabajante JF; Completo GC
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A kinetic modeling platform for predicting the efficacy of siRNA formulations
    Roh EH; Sullivan MO; Epps TH
    STAR Protoc; 2022 Dec; 3(4):101723. PubMed ID: 36313537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol for vision transformer-based evaluation of drug potency using images processed by an optimized Sobel operator.
    Wang Y; Zhang W; Wu Y; Qu C; Hu H; Lee T; Lin S; Zhang J; Lam KS; Wang A
    STAR Protoc; 2023 May; 4(2):102259. PubMed ID: 37133992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Native Mass Spectrometry Meets Glycomics: Resolving Structural Detail and Occupancy of Glycans on Intact Glycoproteins.
    Chen S; Wu D; Robinson CV; Struwe WB
    Anal Chem; 2021 Aug; 93(30):10435-10443. PubMed ID: 34279906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correcting for sparsity and interdependence in glycomics by accounting for glycan biosynthesis.
    Bao B; Kellman BP; Chiang AWT; Zhang Y; Sorrentino JT; York AK; Mohammad MA; Haymond MW; Bode L; Lewis NE
    Nat Commun; 2021 Aug; 12(1):4988. PubMed ID: 34404781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovation Analysis on Postgenomic Biomarkers: Glycomics for Chronic Diseases.
    Adua E; Russell A; Roberts P; Wang Y; Song M; Wang W
    OMICS; 2017 Apr; 21(4):183-196. PubMed ID: 28388299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systems glycobiology for glycoengineering.
    Spahn PN; Lewis NE
    Curr Opin Biotechnol; 2014 Dec; 30():218-24. PubMed ID: 25202878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human disease glycomics: technology advances enabling protein glycosylation analysis - part 1.
    Everest-Dass AV; Moh ESX; Ashwood C; Shathili AMM; Packer NH
    Expert Rev Proteomics; 2018 Feb; 15(2):165-182. PubMed ID: 29285957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A computational framework for the automated construction of glycosylation reaction networks.
    Liu G; Neelamegham S
    PLoS One; 2014; 9(6):e100939. PubMed ID: 24978019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
    Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
    J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive glycoengineering of biosimilars using a Markov chain glycosylation model.
    Spahn PN; Hansen AH; Kol S; Voldborg BG; Lewis NE
    Biotechnol J; 2017 Feb; 12(2):. PubMed ID: 27860290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for analyzing the biosynthesis and degradation of N-glycan precursors in mammalian cells.
    Harada Y; Nakajima K; Li S; Suzuki T; Taniguchi N
    STAR Protoc; 2021 Mar; 2(1):100316. PubMed ID: 33659899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol for predicting drug-resistant protein mutations to an ERK2 inhibitor using RESISTOR.
    Guerin N; Kaserer T; Donald BR
    STAR Protoc; 2023 Apr; 4(2):102170. PubMed ID: 37115667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Released N-Glycan Analysis for Biotherapeutic Development Using Liquid Chromatography and Mass Spectrometry.
    Zhang X
    Methods Mol Biol; 2021; 2261():35-53. PubMed ID: 33420983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.